CANADIAN DOCTOR: 62% OF PATIENTS VACCINATED FOR COVID HAVE

New Post Public Reply Private Reply Replies (1) Message Board
Rusty
237
CANADIAN DOCTOR: 62% OF PATIENTS VACCINATED FOR COVID HAVE PERMANENT HEART DAMAGE

video: https://www.bitchute.com/video/ChQwQBggc8TL/

In this explosive interview of Dr. Charles Hoffe on the Laura Lynn show, Dr. Hoffe explains how he has tested his patients who have received the COVID-19 shots and that 62% of them show blood clotting and permanent damage as a result. "The worst is yet to come" for these patients, he claims. Full interview here: https://www.bitchute.com/video/A6GbcUl6blpJ/

https://healthimpactnews.com/2021/canadian-do...rt-damage/

We have previously covered the story of Dr. Charles Hoffe, the brave doctor who has been practicing medicine for 28 years in the small, rural town of Lytton in British Columbia, Canada.

After he had administered about 900 doses of the Moderna experimental mRNA COVID-19 injections, he sounded the alarm over the severe reactions he was observing in his patients who chose to get the shot (he chose NOT to get it himself), which included death.

The result of him sounding the alarm was a gag order issued against him by the medical authorities in his community. He defied this gag order and was interviewed by Laura-Lynn Tyler Thompson on her show where he sounded the alarm. See:

Canadian Doctor Defies Gag Order and Tells the Public How the Moderna COVID Injections Killed and Permanently Disabled Indigenous People in His Community
His punishment for going public to warn others on the dangers of these experimental shots was that he was relieved from hospital duty and lost half of his income:

Canadian Doctor Removed from Hospital Duty after Speaking out about COVID “Vaccine” Side Effects
Last week, Dr. Hoffe was interviewed again by Laura-Lynn Tyler Thompson, and he continues to share his findings with the public regarding the experimental COVID-19 shots.

Dr. Hoffe is truly a hero today, risking not only his reputation, but probably his very life to bring important information regarding the COVID-19 shots that the Globalists who control the corporate media and social media are trying very hard to censor.

In this latest interview, Dr. Hoffe states that the blood clots that are being reported in the corporate media as being “rare” are anything but rare, based on his own testing of his own patients who had recently received one of the shots.

The blood clots we hear about which the media claim are very rare are the big blood clots which are the ones that cause strokes and show up on CT scans, MRI, etc. The clots I’m talking about are microscopic and too small to find on any scan. They can thus only be detected using the D-dimer test.

Using this test with his own patients, Dr. Hoffe claims that he has found evidence of small blood clots in 62% of his patients who have been injected with an mRNA shot.

He states that these people are now permanently disabled, and they will no longer “be able to do what they used to do.”

These people have no idea they are even having these microscopic blood clots. The most alarming part of this is that there are some parts of the body like the brain, spinal cord, heart and lungs which cannot re-generate. When those tissues are damaged by blood clots they are permanently damaged.

His warning is very dire: “ These shots are causing huge damage and the worst is yet to come. ”

This is an 8 minute clip from the original interview, and we have posted it on our Bitchute channel and Rumble channel.

https://healthimpactnews.com/2021/canadian-do...rt-damage/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Housing Transition: Unlocking the Trillion-Dollar Pathway

Updated Category News Views 44

A Trillion-Dollar Balancing Act at COP31 The housing market: one giant balancing act, now with a trillion bucks at stake. The Sustainable Real Estate Forum (SREF) didn't hold back in their new white paper, "The Trillion-Dollar Housing Transition." They've outlined the monumental shift needed to get our housing not just affordable, but sustainable too. The Lay of the Land...

Continue Reading
Technical Deep Dive into HONOR X9e Pro's Durability

Updated Category News Views 33

Rethinking Smartphone Power HONOR's latest device, the X9e Pro, flaunts an 11,000mAh battery—stuck it right behind a neat cover without making the thing feel like a brick. You'd think with a battery that big, they’d have to hire bodybuilders to lift it, but nope. At 8.08mm thick and weighing just 203g, this phone bucks the bulk. They’ve squeezed the power of a power...

Continue Reading
Chedraui's Q3 '26 Balancing Act: Highlights and Hurdles

Updated Category News Views 79

Mexico's Retail Giant Battles Mixed Outcomes Wading through the latest quarterly scrimmage, Grupo Comercial Chedraui reports that the game plan hasn't changed—stick to low prices, varied assortments, and cracking customer experiences. But the scoreboard's got a few odd numbers, and depending on where you sit, the tally looks slightly uneven. Same Store Sales: A Regional...

Continue Reading
Ozelle's O-Cyte 1: Revolutionizing Hematology with AI

Updated Category News Views 41

O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...

Continue Reading
Lufax's Q3 Struggles: Rising Losses Amid Income Drop

Updated Category News Views 115

Noteworthy Changes in Lufax's Financial Landscape Diving into Lufax's third quarter of 2026, it's clear as day that the numbers are drawing a grim picture. Lufax, a heavyweight in financial services for small business owners in China, announced unflattering financial results. The headline here? A net loss of RMB1,494 million, far from the RMB380 million lost the previous...

Continue Reading
Caylent's Strategic Moves Gain Eyeballs in ISG Report

Updated Category News Views 0

Big Moves in the Contact Center Game There’s a buzz in the tech trenches, folks. Caylent just climbed onto the radar with its prominent mention in the 2026 ISG Provider Lens® Amazon Connect Ecosystem Report. Being dubbed a Product Challenger is no small feat when you’re pitted against some of the giants in tech. What’s their edge? An AI-first strategy, of course,...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 128

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading
NPA Supports 2026 Act Combating Auto Theft Nationwide

Updated Category News Views 29

Tackling Auto Theft with Legislative Might Here's something the crime-riddled cities and anyone with a vehicle should pay attention to: the National Police Association (NPA) is backing the Combatting Auto Robbery at the Source (CARS) Act of 2026. This piece of legislation, shaking the dust off the Capitol's halls, is cooking up a game-changer for law enforcement...

Continue Reading
HDF and IOM Join Forces for Crisis Relief Efforts

Updated Category News Views 41

New Partnership Navigates Humanitarian Complexities Alright, let's cut to the chase. Today, HDF and IOM threw another log on the fire powering humanitarian aid. These big names just inked a Memorandum of Understanding in Geneva, emphasizing their goal of streamlined cooperation to counter crises in Sudan and Yemen. Now, if you're curious about the weight of such...

Continue Reading
Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 52

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Patent Application by Clearmind Advances Mental Health Solutions

Updated Category News Views 125

Clearmind Medicine's Latest Patent Application Highlights Innovations Clearmind Medicine Inc. (Nasdaq: CMND), a pioneering biotech company, is taking bold steps forward in the field of mental health with its recent announcement regarding a U.S. patent application. This publication by the United States Patent and Trademark Office (USPTO) unveils an innovative therapy that...

Continue Reading
Exploring the Advancements in Peanut Allergy Treatments

Updated Category News Views 264

Introduction to Peanut Allergies Peanut allergies are increasingly recognized as a significant health issue, particularly among children. With their prevalence and the growing understanding of their serious implications, this condition has gained considerable attention. Many families, educational institutions, and healthcare providers are more aware of the need for...

Continue Reading
Understanding Elon Musk's Success - The Power of Saying No

Updated Category News Views 303

The Art of Saying No: Insights from Justine Musk Saying "no" can often be one of the most powerful tools in achieving personal success. Justine Musk, the first ex-wife of Elon Musk, emphasizes that this was a defining characteristic of Elon during their time together. Long before attaining the title of the world's richest man, Justine observed his remarkable ability to...

Continue Reading
AllianceBernstein Preparing to Share Q4 2024 Financials Soon

Updated Category News Views 212

AllianceBernstein to Announce Fourth Quarter Results AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) are set to unveil their financial results for the fourth quarter of 2024 ahead of market activities. This highly anticipated announcement will be made public before the market opens on a Thursday. Details of the Upcoming Financial Report Management...

Continue Reading
Cemtrex Sees Promising Growth Amid Financial Challenges

Updated Category News Views 143

Cemtrex's Financial Overview Cemtrex Inc. (NASDAQ: CETX, CETXP), an innovative leader in security technology and industrial services, has showcased its financial performance for the most recent fiscal year. This year highlighted robust revenue increases despite facing various operational challenges. Key Financial Highlights During the fiscal year, the company's revenue...

Continue Reading